Granuflex E: Clinical Trials

4 trials of Granuflex E, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 3 Phase 1, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Early Phase 11Completed 1

Follow Granuflex E: new trials by email Literature Review of Granuflex E trials Research Report on Granuflex E

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults
Formulation A, Formulation B, Formulation C - Gastric Retention, Healthy
Early Phase 1CompletedLyndra Inc.402018-06-252019-02-26
Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants
Formulation A, Formulation B, Formulation C - Healthy
Phase 1CompletedJanssen Sciences Ireland UC122015-03-042018-05-15
Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults
10 μg Na-GST-1/Alhydrogel, 30 μg Na-GST-1/Alhydrogel, 100 μg Na-GST-1/Alhydrogel - Hookworm Infection, Hookworm Disease
Phase 1CompletedBaylor College of Medicine1022011-11-012017-05-31
Bioequivalence and Food Effect Study in Healthy Volunteers
Formulation A, Formulation B, Formulation C - Sleep Initiation and Maintenance Disorders
Phase 1CompletedGlaxoSmithKline162007-07-022017-08-07

Conditions studied

Ancylostomiasis (1)  ·  Anemia, Iron-Deficiency (1)  ·  Hookworm Infections (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Sponsors

Baylor College of Medicine (1)  ·  GlaxoSmithKline (1)  ·  Janssen Sciences Ireland UC (1)  ·  Lyndra Inc. (1)

Countries

Australia (1)  ·  Brazil (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

David Diemert, MD (1)  ·  Sepehr Shakib, MD (1)

Results publications

PMID 28464026

NIH funding

2014 (1)